Sub-Community 伍素瑩 [53/74] 其他 [59/61] 夏克山 [77/157] 岳嶽 [29/34] 張仲明 [7/9] 張俊彥 [23/24] 張竣評 [21/38] 徐祖安 [170/241] 李秀珠 [76/108] 李靜琪 [24/28] 林書玉 [21/31] 洪明秀 [33/44] 潘秀玲(2009-2013) [16/17] 王文傑 [13/15] 王鴻俊 [7/7] 石全(2014-2017) [36/105] 童俊維 [25/25] 紀雅惠 [22/28] 翁紹華 [23/43] 莊宏 [1/1] 葉修華 [25/45] 葉燈光 [137/160] 蔣維棠 [43/99] 謝興邦 [180/261] 趙宇生(2002-2013) [120/279] 郭靜娟 [53/59] 鄒倫 [31/71] 陳志豪 [31/70] 陳新(2002-2015) [53/68] 陳炯東 [184/268] 顏婉菁 [6/8] 許明珠(1997-2001) [3/10] 陳淑貞(1998-2001) [3/11] 陳華鍵(1997-2001) [9/9] Siblings 分子與基因醫學研究所 [942/1007] 生醫工程與奈米醫學研究所 [1237/1432] 免疫醫學研究中心 [237/272] 神經及精神醫學研究中心 [825/878] 細胞及系統醫學研究所 [776/871] 感染症與疫苗研究所 [1577/1704] 群體健康科學研究所 [2942/3077] 癌症研究所 [2310/2499] 國家環境醫學研究所 [1592/1629] 國家蚊媒傳染病防治研究中心 [108/111] 高齡醫學暨健康福祉研究中心 [284/293] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [201/204] 核心儀器設施中心 [9/9] 病理核心實驗室 [15/15] 實驗動物中心 [9/9] 行政管理部門 [20/20] Community Statistics 近3年內發表的文件:121(10.02%) 含全文筆數:856(70.86%) 文件下載次數統計 下載大於0次:1614(188.55%) 下載大於100次:1546(180.61%) 檔案下載總次數:997115(17.03%) 最後更新時間: 2025-04-19 01:53 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 KIF2C promotes paclitaxel resistanc... Identification of PTGR2 inhibitors ... Identification and biological evalu... Tumor cell-derived ISG15 promotes f... Nitrogen, oxygen, and sulphur heter... Prevotella intermedia protease inte... Upregulation of cathepsin S express... Orally bioavailable and site-select... Junceellolide Q, a new polyacetoxyb... Synthesis, anticancer evaluation an...

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-25 / 1208. (共49頁) 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2025-04	Junceellolide Q, a new polyacetoxybriarane from the delicate sea whip octocoral Junceella fragilis	Phytochemistry Letters. 2025 Apr;66:9-14.
2025-03-25	KIF2C promotes paclitaxel resistance by depolymerizing polyglutamylated microtubules	Developmental Cell. 2025 Mar 25;Article in Press.
2025-03-24	Identification and biological evaluation of a novel CLK4 inhibitor targeting alternative splicing in pancreatic cancer using structure-based virtual screening	Advanced Science. 2025 Mar 24;Article in Press.
2025-03-21	Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity	EMBO Molecular Medicine. 2025 Mar 21;Article in Press.
2025-03-11	Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming	Oncogenesis. 2025 Mar 11;14:Article number 6.
2025-03-10	CXCR4 antagonist-loaded nanoparticles reprogram the tumor microenvironment and enhance immunotherapy in hepatocellular carcinoma	Journal of Controlled Release. 2025 Mar 10;379:967-981.
2025-03-05	Upregulation of cathepsin S expression contributes to neuronal damage following kainic acid-induced status epilepticus	Journal of Neurochemistry. 2025 Mar 05;169(3):Article number e70037.
2025-03-05	Nitrogen, oxygen, and sulphur heterocycles as potent anti-inflammatory agents: Insight into the synthetic routes	Chemistryselect. 2025 Mar 05;10(9):Article number e202403824.
2025-02-27	Orally bioavailable and site-selective covalent STING inhibitor derived from a macrocyclic marine diterpenoid	Journal of Medicinal Chemistry. 2025 Feb 27;Article in Press.
2025-02-03	Synthesis, anticancer evaluation and structure-activity relationship of Taiwanin a derivatives	Chemistry of Natural Compounds. 2025 Feb 03;61:11-18.
2025-02	Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin[Erratum:Biochemical Pharmacology. 2023 Jul 20;215:Article number 115688.]	Biochemical Pharmacology. 2025 Feb;232:Article number 116753.
2025-02	Development of BACE2-IN-1/tranylcypromine-based compounds to induce steroidogenesis-dependent neuroprotection	Biomedicine and Pharmacotherapy. 2025 Feb;183:Article number 117851.
2025-01-05	Integrating ultrabright polymer dots and stereo NIR-II imager for assessing anti-angiogenic drugs in oral cancer model	Journal of Cellular and Molecular Medicine. 2025 Jan 05;29(1):Article number e70324.
2025-01-03	Prevotella intermedia protease interpain A promotes human cancer cell lines proliferation and migration	Cancer Science. 2025 Jan 03;116(S1):643.
2025-01	Aldehyde dehydrogenases as drug targets for cancer: SAR and structural biology aspects for inhibitor design	Bioorganic Chemistry. 2025 Jan;154:Article number 108019.
2025-01	Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models	Pharmacological Research. 2025 Jan;211:Article number 107556.
2024-12-30	Novel naphthyridones targeting pannexin 1 for colitis management	Advanced Science. 2024 Dec 30;Article in Press.
2024-12-23	An integrated testing strategy and online tool for assessing skin sensitization of agrochemical formulations	Toxics. 2024 Dec 23;12(12):Article number 936.
2024-12	Discovery of novel TANK-Binding Kinase 1 (TBK1) inhibitor against pancreatic ductal adenocarcinoma	International Journal of Biological Macromolecules. 2024 Dec;283(Part 1):Article number 137296.
2024-12	Alkoxylation of ketone mediated by N-heterocyclic carbene borane and sulfuric acid in alcohol	Asian Journal of Organic Chemistry. 2024 Dec;13(12):Article number e202400436.
2024-11-30	Generation of quaternary carbons in cycloalkanones and lactones with arynes through a domino process	Journal of Organic Chemistry. 2024 Nov 30;89(24):18393-18399.
2024-11-26	Development of potent and selective inhibitors of methylenetetrahydrofolate dehydrogenase 2 for targeting acute myeloid leukemia: Sar, structural insights, and biological characterization	Journal of Medicinal Chemistry. 2024 Nov 26;67(23):21106-21125.
2024-11-21	Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia	Cell Chemical Biology. 2024 Nov 21;31(11):1885-1898.e10.
2024-11-13	Beta-d-Ribofuranose as a core with a phosphodiester moiety as the enzyme recognition site for codrug development	Organic letters. 2024 Nov 13;Article in Press.
2024-11-07	Discovery of DYRK1A inhibitors as potential treatment of pancreatic ductal adenocarcinoma (PDAC)	Asia-Pacific Journal of Clinical Oncology. 2024 Nov 07;20:116.

顯示項目1-25 / 1208. (共49頁) 1 2 3 4 5 6 7 8 9 10 > >> 每頁顯示[10|25|50]項目